Nyheter
FinELib and Sage have renewed their Read & Publish agreement for 2025–2026, with an option to extend until 2027.
→ Läs meraAgreements enable access to articles behind paywalls and open access publishing without costs for researchers.
→ Läs meraAre you planning on publishing your article open access under a FinELib agreement? Check what you need to know.
→ Läs meraNegotiations for 2025 have ended. FinELib consortium will not sign an agreement with American Chemical Society.
→ Läs meraThere will be no consortium agreement for 2024, but negotiations will continue for the year 2025.
→ Läs meraNew agreements will ensure continuation of open access publishing, guarantee access to journals, and keep the expenses of scientific publishing moderate.
→ Läs meraAccess to new, 2024 published ACS articles has been cut, and open access publishing under FinELib agreements has ended.
→ Läs meraFinELib has made progress in negotiating with scholarly publishers, and negotiations continue in the new year.
→ Läs meraUtnyttja Open access -fördelar
Vid förhandlingarna har man kommit överens om open access-fördelar för följande förläggares tidskrifter.
Mer information om open access-fördelar för olika förläggare och organisationer får du även på ditt eget bibliotek.